相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Ken Inoki et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
Feng Qian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1-Signaling Pathway
Jung Min Han et al.
CELL (2012)
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Courtney Smith et al.
CANCER DISCOVERY (2012)
A perspective on new immune adjuvant principles Reprogramming inflammatory states to permit clearance of cancer cells and other age-associated cellular pathologies
George C. Prendergast et al.
ONCOIMMUNOLOGY (2012)
Signalling by amino acid nutrients
Lijun Yan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase
Mee Young Chang et al.
CANCER BIOLOGY & THERAPY (2011)
Leucine Deprivation Increases Hepatic Insulin Sensitivity via GCN2/mTOR/S6K1 and AMPK Pathways
Fei Xiao et al.
DIABETES (2011)
Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells
Rui Zeng et al.
HEART AND VESSELS (2011)
Physiologic Control of the Functional Status of Foxp3+ Regulatory T Cells
Andrew L. Mellor et al.
JOURNAL OF IMMUNOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells
Huai-Chia Chuang et al.
NATURE IMMUNOLOGY (2011)
The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
Christiane A. Opitz et al.
PLOS ONE (2011)
Towards a Genetic Definition of Cancer-Associated Inflammation Role of the IDO Pathway
George C. Prendergast et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion
Alexander J. Muller et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
mTOR signalling and metabolic regulation of T cell differentiation
Christian Peter et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Integration of General Amino Acid Control and Target of Rapamycin (TOR) Regulatory Pathways in Nitrogen Assimilation in Yeast
Kirk A. Staschke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Snf1 Promotes Phosphorylation of the α Subunit of Eukaryotic Translation Initiation Factor 2 by Activating Gcn2 and Inhibiting Phosphatases Glc7 and Sit4
Vera Cherkasova et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
D-Amino Acids Trigger Biofilm Disassembly
Ilana Kolodkin-Gal et al.
SCIENCE (2010)
mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat
Nattida Chotechuang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
Agnieszka K. Witkiewicz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
PKCθ cooperates with PKCα in alloimmune responses of T cells in vivo
Thomas Gruber et al.
MOLECULAR IMMUNOLOGY (2009)
Halofuginone Inhibits TH17 Cell Differentiation by Activating the Amino Acid Starvation Response
Mark S. Sundrud et al.
SCIENCE (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Differential requirement of PKC-θ in the development and function of natural regulatory T cells
Sonal Gupta et al.
MOLECULAR IMMUNOLOGY (2008)
Immune escape as a fundamental trait of cancer: focus on IDO
G. C. Prendergast
ONCOGENE (2008)
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
Alexander J. Muller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling
Greg M. Findlay et al.
BIOCHEMICAL JOURNAL (2007)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-κB induction
Y Liu et al.
BIOCHEMICAL JOURNAL (2002)
分享论文
